S100A7A and psoriasis: Researches [24,260,261] show a broader spectrum of S100A15 activity as a mediator of inflammation, not only in the skin but also beyond, which may have systemic consequences in the form of comorbidities in psoriasis, such as atherosclerosis and obesity.